Cambridge Innovation Capital

Investment thesis

Cambridge-based VC investing in high-potential deep tech and life sciences companies, with a proprietary relationship with the University of Cambridge giving privileged access to its ideas and people. Primarily a Series A investor with growth-stage capability; ~GBP 0.6bn AUM. Launched Fund III and an Opportunity fund (backed by Aviva and British Patient Capital) for later-stage rounds.

Notable portfolio

Sector focus